{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Autoimmune disease", "CD56bright NK cell", "Cytokine", "Immunology", "Regulatory NK cell"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37275764", "DateRevised": {"Year": "2023", "Month": "06", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.22038/IJBMS.2023.68653.14969"], "Journal": {"ISSN": "2008-3866", "JournalIssue": {"Volume": "26", "Issue": "6", "PubDate": {"Year": "2023"}}, "Title": "Iranian journal of basic medical sciences", "ISOAbbreviation": "Iran J Basic Med Sci"}, "ArticleTitle": "Regulatory NK cells in autoimmune disease.", "Pagination": {"StartPage": "609", "EndPage": "616", "MedlinePgn": "609-616"}, "Abstract": {"AbstractText": ["NK cells are defined as the major components of the immunological network which exerts defense against tumors and viral infections as well as regulation of innate and adaptive immunity, shaped through interaction with other cells like T cells. According to the surface markers, NK cells can be divided into CD56dim NK and CD56bright NK subsets. CD56bright NK cells usually are known as regulatory NK cells. Once the immune system loses its self-tolerance, autoimmune diseases develop. NK cells and their subsets can be altered during autoimmune diseases, indicative of their prominent regulatory roles and even pathological and protective functions in autoimmune disorders. In this regard, activation of CD56bright NK cells can suppress activated autologous CD4+ T cells and subsequently prevent the initiation of autoimmunity. In this review article, we summarize the roles of regulatory NK cells in autoimmune disease occurrence which needs more research to uncover their exact related mechanism. It seems that targeting NK cells can be a promising therapeutic platform against autoimmune diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Bahadorian", "ForeName": "Davood", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Engineering, Faculty of New Sciences and Technology, University of Tehran, Tehran, Iran."}], "LastName": "Mirazi", "ForeName": "Hosein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Sciences, College of Medicine, Hawler Medical University, Erbil, Iraq."}, {"Identifier": [], "Affiliation": "Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq."}], "LastName": "Faraj", "ForeName": "Tola Abdulsattar", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Laboratory Science Department, College of Science, University of Raparin, Rania, Sulaymaniyah, Iraq."}, {"Identifier": [], "Affiliation": "Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq."}], "LastName": "Kheder", "ForeName": "Ramiar Kamal", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Esmaeili", "ForeName": "Seyed-Alireza", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Iran J Basic Med Sci", "NlmUniqueID": "101517966", "ISSNLinking": "2008-3866"}, "CoiStatement": "The authors declare no competing financial or non-financial interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Delves PJ, Roitt IM. The immune system. New Eng J Med. 2000;343:37\u201349.", "ArticleIdList": ["10882768"]}, {"Citation": "Karami K, Rafiee M, Lighvan ZM, Zakariazadeh M, Faal AY, Esmaeili S-A, et al. Synthesis, spectroscopic characterization and in vitro cytotoxicities of new organometallic palladium complexes with biologically active \u03b2-diketones; Biological evaluation probing of the interaction mechanism with DNA/Protein and molecular docking. J Mol Struct. 2018;1154:480\u2013495."}, {"Citation": "Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267\u20131284.", "ArticleIdList": ["PMC6169832", "30275043"]}, {"Citation": "Shete MV, Deshmukh RS, Kulkarni T, Shete AV, Karande P, Hande P. Myofibroblasts as important diagnostic and prognostic indicators of oral squamous cell carcinoma: an immunohistochemical study in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma. J Carcinog. 2020;19:1\u201313.", "ArticleIdList": ["PMC7279625", "32684849"]}, {"Citation": "Parkin J, Cohen B. An overview of the immune system. Lancet. 2001;357:1777\u20131789.", "ArticleIdList": ["11403834"]}, {"Citation": "Eisenberg R. Do autoantigens define autoimmunity or vice versa? Eur J Immunol. 2005;35:367\u2013370.", "ArticleIdList": ["15627973"]}, {"Citation": "Leng Q, Bentwich Z. Beyond self and nonself: fuzzy recognition of the immune system. Scand J Immunol. 2002;56:224\u2013232.", "ArticleIdList": ["12193223"]}, {"Citation": "Shakerian L, Kolahdooz H, Garousi M, Keyvani V, Kheder RK, Faraj TA, et al. IL-33/ST2 axis in autoimmune disease. Cytokine. 2022;158:156015.", "ArticleIdList": ["36041312"]}, {"Citation": "Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili S-A. SARS-CoV-2 triggering autoimmune diseases. Cytokine . 2022:155873\u2013155882.", "ArticleIdList": ["PMC8979824", "35461172"]}, {"Citation": "Gross CC, Schulte-Mecklenbeck A, Wiendl H, Marcenaro E, Kerlero de Rosbo N, Uccelli A, et al. Regulatory functions of natural killer cells in multiple sclerosis. Front Immunol. 2016;7:606\u2013614.", "ArticleIdList": ["PMC5165263", "28066417"]}, {"Citation": "DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM. Autoantigen-specific TGF\u03b2-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol. 2007;179:4685\u20134693.", "ArticleIdList": ["17878367"]}, {"Citation": "Karopka T, Fluck J, Mevissen H-T, Glass \u00c4. The autoimmune disease database: a dynamically compiled literature-derived database. BMC Bioinformatics. 2006;7:1\u201317.", "ArticleIdList": ["PMC1525205", "16803617"]}, {"Citation": "Khorasani S, Mahmoudi M, Kalantari MR, Lavi Arab F, Esmaeili SA, Mardani F, et al. Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model. J Cell Physiol. 2019;234:9778\u20139786.", "ArticleIdList": ["30370554"]}, {"Citation": "Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME. Definition of human autoimmunity\u2014autoantibodies versus autoimmune disease. Autoimmun Rev. 2010;9:259\u2013266.", "ArticleIdList": ["19963079"]}, {"Citation": "Esmaeili SA, Mahmoudi M, Momtazi AA, Sahebkar A, Doulabi H, Rastin M. Tolerogenic probiotics: potential immunoregulators in systemic lupus erythematosus. J Cell Physiol. 2017;232:1994\u20132007.", "ArticleIdList": ["27996081"]}, {"Citation": "Rose NR. Prediction and prevention of autoimmune disease in the 21st century: a review and preview. Am J Epidemiol. 2016;183:403\u2013406.", "ArticleIdList": ["26888748"]}, {"Citation": "Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015;3:151\u2013155."}, {"Citation": "Ji J, Sundquist J, Sundquist K. Gender-specific incidence of autoimmune diseases from national registers. J Autoimmun. 2016;69:102\u2013106.", "ArticleIdList": ["26994904"]}, {"Citation": "Bachmann MF, Kopf M. On the role of the innate immunity in autoimmune disease. J Exp Med. 2001;193:47\u201350.", "ArticleIdList": ["PMC2193298", "11413199"]}, {"Citation": "Duan L, Rao X, Sigdel KR. Regulation of inflammation in autoimmune disease. J Immunol Res. 2019;2019:1\u20132.", "ArticleIdList": ["PMC6421792", "30944837"]}, {"Citation": "Esmaeili SA, Mahmoudi M, Rezaieyazdi Z, Sahebari M, Tabasi N, Sahebkar A, et al. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics. J Cell Biochem. 2018;119:7865\u20137872.", "ArticleIdList": ["29943843"]}, {"Citation": "Mu\u00f1oz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, et al. Autoimmunity and chronic inflammation\u2014two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev. 2010;10:38\u201342.", "ArticleIdList": ["20817127"]}, {"Citation": "Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR, et al. The immunomodulatory effects of mesenchymal stromal cell\u2010based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life. 2020;72:2366\u20132381.", "ArticleIdList": ["33006813"]}, {"Citation": "Leavenworth JW, Wang X, Wenander CS, Spee P, Cantor H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sciences U S A. 2011;108:14584\u201314589.", "ArticleIdList": ["PMC3167502", "21873193"]}, {"Citation": "Yang Y, Day J, Souza\u2010Fonseca Guimaraes F, Wicks IP, Louis C. Natural killer cells in inflammatory autoimmune diseases. Clin Transl Immunology. 2021;10:1250\u20131267.", "ArticleIdList": ["PMC7850912", "33552511"]}, {"Citation": "Samadi-Khouzani A, Parizi PK, Ghafari F, Esmaeili S-A, Peymani M, Momtazi-Borojeni AA. Association between rs619586 (A/G) polymorphism in the gene encoding lncRNA-MALAT1 with type 2 diabetes susceptibility among the Isfahan population in Iran. Int J Diabetes Dev Ctries. 2021;42:77\u201381."}, {"Citation": "Liu M, Liang S, Zhang C. NK cells in autoimmune diseases: protective or pathogenic? Front Immunolo. 2021;12:701\u2013715.", "ArticleIdList": ["PMC7994264", "33777006"]}, {"Citation": "Perera Molligoda Arachchige AS. Human NK cells: from development to effector functions. Innate Immun. 2021;27:212\u2013229.", "ArticleIdList": ["PMC8054151", "33761782"]}, {"Citation": "Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat Rev Immunol. 2011;11:645\u2013657.", "ArticleIdList": ["PMC4408539", "21869816"]}, {"Citation": "Vivier E, Toselo E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503\u2013510.", "ArticleIdList": ["18425107"]}, {"Citation": "Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr Opin Immunol. 2013;25:53\u201358.", "ArticleIdList": ["23270590"]}, {"Citation": "Schuster IS, Coudert JD, Andoniou CE, Degli-Esposti MA. \u201cNatural regulators\u201d: NK cells as modulators of T cell immunity. Front Immunol. 2016;7:235\u2013241.", "ArticleIdList": ["PMC4905977", "27379097"]}, {"Citation": "Mody CH, Ogbomo H, Xiang RF, Kyei SK, Feehan D, Islam A, et al. Microbial killing by NK cells. J Leukoc Biol. 2019;105:1285\u20131296.", "ArticleIdList": ["30821868"]}, {"Citation": "Baroroh HN, Nugroho AE, Lukitaningsih E, Nurrochmad A. Immune-enhancing effect of bengkoang (Pachyrhizus erosus (L ) Urban) fiber fractions on mouse peritoneal macrophages, lymphocytes, and cytokines. J Nat Sci Biol Med. 2021;12:84\u201392."}, {"Citation": "Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013;31:227\u2013258.", "ArticleIdList": ["PMC3868343", "23516982"]}, {"Citation": "Chen Y, Lu D, Churov A, Fu R. Research progress on NK cell receptors and their signaling pathways. Mediators Inflamm. 2020;2020:1\u201314.", "ArticleIdList": ["PMC7396059", "32774149"]}, {"Citation": "Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol. 1995;154:5144\u20135152.", "ArticleIdList": ["7730620"]}, {"Citation": "Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol. 1998;161:1962\u20131969.", "ArticleIdList": ["9712067"]}, {"Citation": "Martinez-Espinosa I, Serrato JA, Ortiz-Quintero B. Role of IL-10-producing natural killer cells in the regulatory mechanisms of inflammation during systemic infection. Biomolecules. 2021;12:4\u201325.", "ArticleIdList": ["PMC8773486", "35053151"]}, {"Citation": "Zhang C, Tian Z. NK cell subsets in autoimmune diseases. J Autoimmun. 2017;83:22\u201330.", "ArticleIdList": ["28285736"]}, {"Citation": "Adnan Mezher M, Bahjat Alrifai S, Mahmood Raoof W. Analysis of proinflammatory cytokines in COVID-19 patients in Baghdad, Iraq. Arch Razi Instit. 2022;1:305\u2013313."}, {"Citation": "Peng H, Tian Z. Diversity of tissue-resident NK cells. Semin Immunol. 2017:3\u201310.", "ArticleIdList": ["28802693"]}, {"Citation": "Mimpen M, Smolders J, Hupperts R, Damoiseaux J. Natural killer cells in multiple sclerosis: a review. Immunol Lett. 2020;222:1\u201311.", "ArticleIdList": ["32113900"]}, {"Citation": "Laroni A, Uccelli A. CD56bright natural killer cells: a possible biomarker of different treatments in multiple sclerosis. J Clin Med. 2020;9:1450\u20131463.", "ArticleIdList": ["PMC7291063", "32414131"]}, {"Citation": "Olek M, Joseph AP. Cryo-EM map-based model validation using the false discovery rate approach. Front Mol Biosci. 2021;8:652530\u2013652546.", "ArticleIdList": ["PMC8167059", "34084774"]}, {"Citation": "Atabati H, Yazdanpanah E, Mortazavi H, Raoofi A, Esmaeili S-A, Khaledi A, et al. Immunoregulatory effects of tolerogenic probiotics in multiple sclerosis. Adv Exp Med Biol. 2021;1286:87\u2013105.", "ArticleIdList": ["33725347"]}, {"Citation": "Hassanshahi G, Roohi MA, Esmaeili S-A, Pourghadamyari H, Nosratabadi R. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients. Cytokine. 2021;148:155706.", "ArticleIdList": ["34583254"]}, {"Citation": "Laroni A, Gandhi R, Beynon V, Weiner HL. IL-27 imparts immunoregulatory function to human NK cell subsets. PloS One. 2011;6:26173\u201326179.", "ArticleIdList": ["PMC3198386", "22039443"]}, {"Citation": "Laroni A, Armentani E, de Rosbo NK, Ivaldi F, Marcenaro E, Sivori S, et al. Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis. J Autoimmun. 2016;72:8\u201318.", "ArticleIdList": ["27157273"]}, {"Citation": "Dunphy S, Gardiner CM. NK cells and psoriasis. J Biomed Biotechnol. 2011;2011:1\u201310.", "ArticleIdList": ["PMC3114545", "21687543"]}, {"Citation": "Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93:97\u2013110.", "ArticleIdList": ["PMC7087066", "32226340"]}, {"Citation": "Atabati H, Esmaeili SA, Saburi E, Akhlaghi M, Raoofi A, Rezaei N, et al. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: evidence from experimental and clinical studies. J Cell Physiol. 2020;235:8925\u20138937.", "ArticleIdList": ["32346892"]}, {"Citation": "Arjuna S, Chakraborty G, Venkataram R, Dechamma PN, Chakraborty A. Detection of epidermal growth factor receptor T790M mutation by allele-specific loop mediated isothermal amplification. J Carcinog. 2020;19:3\u201319.", "ArticleIdList": ["PMC7363156", "32684851"]}, {"Citation": "Ottaviani C, Nasorri F, Bedini C, de Pit\u00e0 O, Girolomoni G, Cavani A. CD56brightCD16\u2013NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36:118\u2013128.", "ArticleIdList": ["16323244"]}, {"Citation": "Hegab DS, Elgarhy LH, Attia M. Are peripheral natural killer cells and interleukin-21 interrelated in psoriasis pathogenesis? Ann Dermatol. 2017;29:108\u2013110.", "ArticleIdList": ["PMC5318508", "28223760"]}, {"Citation": "Sato Y, Ogawa E, Okuyama R. Role of innate immune cells in psoriasis. Int J Mol Sci. 2020;21:6604\u20136621.", "ArticleIdList": ["PMC7554918", "32917058"]}, {"Citation": "Michel T, Poli A, Cuapio A, Briquemont B, Iserentant G, Ollert M, et al. Human CD56bright NK cells: an update. J Imunol. 2016;196:2923\u20132931.", "ArticleIdList": ["26994304"]}, {"Citation": "Cameron A, Kirby B, Griffiths C. Circulating natural killer cells in psoriasis. Br J Dermatol. 2003;149:160\u2013164.", "ArticleIdList": ["12890211"]}, {"Citation": "Yazdanpanah E, Mahmoudi M, Sahebari M, Rezaieyazdi Z, Esmaeili SA, Tabasi N, et al. Vitamin D3 alters the expression of toll-like receptors in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. J Cell Biochem. 2017;118:4831\u20134835.", "ArticleIdList": ["28544067"]}, {"Citation": "Liu M, Liu J, Zhang X, Xiao Y, Jiang G, Huang X. Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol. 2021;40:1103\u20131112.", "ArticleIdList": ["32797360"]}, {"Citation": "Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, K\u00e4rre K, et al. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology. 2009;126:140\u2013146.", "ArticleIdList": ["PMC2632704", "18564343"]}, {"Citation": "Luo Q, Li X, Fu B, Zhang L, Deng Z, Qing C, et al. Decreased expression of TIGIT in NK cells correlates negatively with disease activity in systemic lupus erythematosus. Int J Clin Exp Pathol. 2018;11:2408\u20132418.", "ArticleIdList": ["PMC6958272", "31938353"]}, {"Citation": "Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98:479\u2013487.", "ArticleIdList": ["26216938"]}, {"Citation": "Yamin R, Berhani O, Peleg H, Aamar S, Stein N, Gamliel M, et al. High percentages and activity of synovial fluid NK cells present in patients with advanced stage active rheumatoid arthritis. Sci Rep. 2019;9:1\u201312.", "ArticleIdList": ["PMC6361912", "30718650"]}, {"Citation": "Zafari P, Rafiei A, Esmaeili SA, Moonesi M, Taghadosi M. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J Cell Physiol. 2019;234:21575\u201321587.", "ArticleIdList": ["31062383"]}, {"Citation": "Khaledi A, Khademi F, Esmaeili D, Esmaeili S-A, Rostami H. The role of HPaA protein as candidate vaccine against Helicobacter pylori. Der Pharma Chemica. 2016;8:235\u2013237."}, {"Citation": "Fathollahi A, Samimi LN, Akhlaghi M, Jamshidi A, Mahmoudi M, Farhadi E. The role of NK cells in rheumatoid arthritis. Inflamm Res. 2021;70:1063\u20131073.", "ArticleIdList": ["34580740"]}, {"Citation": "Dalbeth N, Callan MF. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum. 2002;46:1763\u20131772.", "ArticleIdList": ["12124859"]}, {"Citation": "Dalbeth N, Gundle R, Davies RJ, Lee YG, McMichael AJ, Callan MF. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol. 2004;173:6418\u20136426.", "ArticleIdList": ["15528382"]}, {"Citation": "Feng S, Madsen SH, Viller NN, Neutzsky\u2010Wulff AV, Geisler C, Karlsson L, et al. Interleukin\u201015\u2010activated natural killer cells kill autologous osteoclasts via LFA\u20101, DNAM\u20101 and TRAIL, and inhibit osteoclast\u2010mediated bone erosion in vitro. Immunology. 2015;145:367\u2013379.", "ArticleIdList": ["PMC4479536", "25684021"]}, {"Citation": "Takeda H, Kikuchi T, Soboku K, Okabe I, Mizutani H, Mitani A, et al. Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture. Inflammation. 2014;37:657\u2013669.", "ArticleIdList": ["24287823"]}, {"Citation": "Zaiatz Bittencourt V, Jones F, Tosetto M, Doherty GA, Ryan EJ. Dysregulation of metabolic pathways in circulating natural killer cells isolated from inflammatory bowel disease patients. J Crohns Colitis. 2021;15:1316\u20131325.", "ArticleIdList": ["PMC8328302", "33460436"]}, {"Citation": "Poggi A, Benelli R, Ven\u00e8 R, Costa D, Ferrari N, Tosetti F, et al. Human gut-associated natural killer cells in health and disease. Front Immunol. 2019;10:961\u2013979.", "ArticleIdList": ["PMC6509241", "31130953"]}, {"Citation": "Samarani S, Sagala P, Jantchou P, Grimard G, Faure C, Deslandres C, et al. Phenotypic and functional changes in peripheral blood natural killer cells in crohn disease patients. Med Inflamm. 2020;2020:1\u201318.", "ArticleIdList": ["PMC7049869", "32148442"]}, {"Citation": "Qasim S, Alamgeer , Saleem M, Alotaibi NH, Bukhari SNA, Alharbi KS, et al. Appraisal of the antiarthritic potential of prazosin via inhibition of proinflammatory cytokine TNF-\u03b1: a key player in rheumatoid arthritis. ACS Omega. 2021;6:2379\u20132388.", "ArticleIdList": ["PMC7841939", "33521476"]}, {"Citation": "Dunphy S, Gardiner CM. NK cells and psoriasis. J Biomed Biotechnol. 2011;2011:248317\u2013248327.", "ArticleIdList": ["PMC3114545", "21687543"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "26"}, {"Year": "2023", "Month": "2", "Day": "8"}, {"Year": "2023", "Month": "6", "Day": "5", "Hour": "19", "Minute": "11"}, {"Year": "2023", "Month": "6", "Day": "5", "Hour": "19", "Minute": "10"}, {"Year": "2023", "Month": "6", "Day": "5", "Hour": "12", "Minute": "21"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37275764", "PMC10237161", "10.22038/IJBMS.2023.68653.14969"]}}], "PubmedBookArticle": []}